PEAK6 Group’s NeoGenomics NEO Stock Holding History

PEAK6 Group’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-53,217	Closed	-$592K	–	4554
2017 Q3	$592K	Buy	+53,217	New	+$518K	﹤0.01%	2413

Other funds holding NEO

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

PEAK6 Group's NEO Position: Q4 2017 in Review

PEAK6 Group sold out of NeoGenomics (NEO) in Q4 2017, closing a stake of 53,217 shares — an estimated $592K sold.

PEAK6 Group first reported a position in NEO in Q3 2017 and held it in 1 quarter. The position peaked at $592K in Q3 2017. 132 funds tracked by Wall St. Rank hold NEO as of Q4 2017.

PEAK6 Group reported no remaining NeoGenomics position as of Q4 2017 after selling out during the quarter.
PEAK6 Group sold 53,217 NeoGenomics shares in Q4 2017, an estimated $592K.
PEAK6 Group first reported a position in NeoGenomics in Q3 2017 and held it in 1 quarter.
PEAK6 Group's NeoGenomics position peaked at $592K in Q3 2017.
132 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.